WASHINGTON — Key Senate lawmakers have begun writing a bipartisan bill that would cap the prices patients pay for insulin — and target the strategies drugmakers use to set prices for the medicine, too.
The package, from Sens. Jeanne Shaheen (D-N.H.) and Sen. Susan Collins (R-Maine), would go beyond the $35-a-month cap lawmakers have been talking about for months, Shaheen suggested in a brief interview with STAT on Tuesday.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
